Cardiomyopathy clinical trials at UCSD
2 in progress, 1 open to eligible people
open to eligible people ages 18 years and up
Open label study to evaluate tafamidis for the treatment of transthyretin cardiomyopathy
La Jolla, California and other locations
Sorry, in progress, not accepting new patients
The goal is to determine how lifestyle and exercise impact the well-being of individuals with hypertrophic cardiomyopathy (HCM) and long QT syndrome (LQTS).
San Diego, California and other locations